Interactions between Atazanavir-Ritonavir and Tenofovir in Heavily Pretreated Human Immunodeficiency Virus-Infected Patients

類似資料

• Predictive Values of the Human Immunodeficiency Virus Phenotype and Genotype and of Amprenavir and Lopinavir Inhibitory Quotients in Heavily Pretreated Patients on a Ritonavir-Boosted Dual-Protease-Inhibitor Regimen
  著者:: Barrail-Tran, Aurélie, 等
  出版事項: (2008)
• Safety of atazanavir/ritonavir with tenofovir disoproxil fumarate in HIV-infected adolescents
  著者:: T. Bunupuradah, 等
  出版事項: (2014-04-01)
• Influence of Alpha-1 Glycoprotein Acid Concentrations and Variants on Atazanavir Pharmacokinetics in HIV-Infected Patients Included in the ANRS 107 Trial
  著者:: Barrail-Tran, A., 等
  出版事項: (2010)
• Interaction Between Buprenorphine and Atazanavir or Atazanavir/Ritonavir
  著者:: McCance-Katz, Elinore F., 等
  出版事項: (2007)
• Virological and Pharmacological Parameters Predicting the Response to Lopinavir-Ritonavir in Heavily Protease Inhibitor-Experienced Patients
  著者:: Marcelin, Anne-Geneviève, 等
  出版事項: (2005)